Ocrelizumab
Products in Health Canada’s databases that list Ocrelizumab as a medicinal or active ingredient, under this spelling. The same substance can be listed under another name (a salt, a common name), which has its own page.
- Drug products
- 1
- 1 authorized now
- Natural health products
- 0
- 0 active licences
- Notices of Compliance
- 10
- Products in all
- 1
Drug products
Authorized products first.
| Name | DIN | Status | Holder | Status since |
|---|---|---|---|---|
| OCREVUS (30 MG) | 02467224 | Marketed | Hoffmann-La Roche Limited |
Notices of Compliance
Approvals of drug submissions that list it, newest first.
- OCREVUSSeptember 17, 2026 · NOC 38303
- OCREVUSMay 15, 2026 · NOC 37548
- OCREVUSFebruary 17, 2026 · NOC 36924
- OCREVUSAugust 21, 2023 · NOC 31462
- OCREVUSJanuary 9, 2023 · NOC 29863
- OCREVUSApril 1, 2021 · NOC 25598
- OCREVUSJuly 31, 2020 · NOC 23984
- OCREVUSApril 9, 2019 · NOC 22045
- OCREVUSFebruary 14, 2018 · NOC 20482
- OCREVUSAugust 14, 2017 · NOC 19940